Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors

被引:29
作者
Ciobanu, LC [1 ]
Luu-The, V [1 ]
Poirier, D [1 ]
机构
[1] CHUQ, Div Med Chem, Oncol & Mol Endocrinol Res Ctr, St Foy, PQ G1V 4G2, Canada
基金
英国医学研究理事会;
关键词
sulfatase; inhibitor; phenol; sulfamate; steroid;
D O I
10.1016/S0960-0760(02)00024-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical synthesis and enzyme inhibition results are reported for a series of nonsteroidal sulfatase inhibitors, 1-(p-sulfamoyloxyphenyl)5-(p-t-butylbenzyl)-5-alkanols and the lower active phenolic analogues. These compounds conserve some structural elements from the previously reported potent steroidal inhibitor 3-O-sulfamate-17alpha-(p-t-butylbenzyl)-17beta-hydroxy-estra-1,3,5(10)-triene, while the C18-methyl group and the hydrocarbon backbone represented by the steroid rings B, C, and D were replaced with a free conformational chain. Using estrone sulfate (100 muM) as substrate and homogenate of transfected HEK-293 cells as source of steroid sulfatase activity, the IC50 values of the best inhibitors, the undecanol derivatives, were 0.4mu+/-0. 1 and >300 nM, respectively, in the sulfamate and phenolic series. Although these sulfamoylated nonsteroidal inhibitors appear a bit less active than their steroidal analogues, they are however more potent than known inhibitors estrone-3-O-sulfamate and p-(O-sulfamoyl)-N-tetradecanoyl tyramine. The optimal side-chain length for the inhibition of steroid sulfatase activity was found to be six carbons, which corresponds to the number of carbons that mimic the B, C and D steroid rings, between C6 and C17. Furthermore, compounds with only the t-butylbenzyl group or the alkyl chain of six carbons are less potent inhibitors compared to the one that include both of these hydrophobic substituents. Such results suggest that compound from this later category better mimic the steroidal inhibitor. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:339 / 353
页数:15
相关论文
共 43 条
[1]   CONTROL OF SECRETION AND THE FUNCTION OF C-19-DELTA-5-STEROIDS OF THE HUMAN ADRENAL-GLAND [J].
ADAMS, JB .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1985, 41 (01) :1-17
[2]   ENZYMES OF ANDROGEN FORMATION AND DEGRADATION IN THE HUMAN PROSTATE [J].
BARTSCH, W ;
KLEIN, H ;
SCHIEMANN, U ;
BAUER, HW ;
VOIGT, KD .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 595 :53-66
[3]   Structure-activity relationships of 17α-derivatives of estradiol as inhibitors of steroid sulfatase [J].
Boivin, RP ;
Luu-The, V ;
Lachance, R ;
Labrie, F ;
Poirier, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4465-4478
[4]   17α-Alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity [J].
Boivin, RP ;
Labrie, F ;
Poirier, D .
STEROIDS, 1999, 64 (12) :825-833
[5]  
BOIVIN RP, 1994, SYNTHESE CHIMIQUE IN
[6]   ADRENAL ANDROGEN CONCENTRATIONS IN BREAST-TUMORS AND IN NORMAL BREAST-TISSUE - THE RELATIONSHIP TO ESTRADIOL METABOLISM [J].
BONNEY, RC ;
SCANLON, MJ ;
REED, MJ ;
JONES, DL ;
BERANEK, PA ;
JAMES, VHT .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (01) :501-504
[7]   ONE-POT TRANSFORMATION OF CARBOXYLIC-ACIDS INTO ALDEHYDES THROUGH STEPWISE TREATMENT OF ACYLOXY-9-BORABICYCLO(3.3.1)NONANES WITH TERT-BUTYLLITHIUM AND 9-BORABICYCLO(3.3.1)NONANE [J].
CHA, JS ;
KIM, JE ;
YOON, MS ;
KIM, YS .
TETRAHEDRON LETTERS, 1987, 28 (49) :6231-6234
[8]   Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors [J].
Chu, GH ;
Milano, S ;
Kluth, L ;
Rhodes, M ;
Boni, R ;
Johnson, DA ;
Li, PK .
STEROIDS, 1997, 62 (07) :530-535
[9]   Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17α-benzyl(or 4′-tert-butylbenzyl)estra-1,3,5(10)-trienes:: Combination of two substituents at positions C3 and C17α of estradiol [J].
Ciobanu, LC ;
Boivin, RP ;
Luu-The, V ;
Labrie, F ;
Poirier, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) :2280-2286
[10]   Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry [J].
El-Alfy, M ;
Luu-The, V ;
Huang, XF ;
Berger, L ;
Labrie, F ;
Pelletier, G .
ENDOCRINOLOGY, 1999, 140 (03) :1481-1491